Daniel M. Moreira

ORCID: 0000-0003-4517-244X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Cancer, Lipids, and Metabolism
  • Renal cell carcinoma treatment
  • Bladder and Urothelial Cancer Treatments
  • Hormonal and reproductive studies
  • Renal and related cancers
  • Urinary Bladder and Prostate Research
  • Kidney Stones and Urolithiasis Treatments
  • Inflammatory Biomarkers in Disease Prognosis
  • Pediatric Urology and Nephrology Studies
  • Urologic and reproductive health conditions
  • Lipoproteins and Cardiovascular Health
  • Cancer Risks and Factors
  • Pelvic floor disorders treatments
  • Genital Health and Disease
  • Global Cancer Incidence and Screening
  • Statistical Methods in Clinical Trials
  • Renal and Vascular Pathologies
  • Metabolism, Diabetes, and Cancer
  • Urological Disorders and Treatments
  • Colorectal Cancer Screening and Detection
  • Inflammatory mediators and NSAID effects
  • Multiple and Secondary Primary Cancers
  • Sexual function and dysfunction studies

University of Illinois Chicago
2016-2024

Illinois College
2020-2024

University of Minnesota
2024

University of Illinois Urbana-Champaign
2019-2023

Universidade de Brasília
2022

University of Aveiro
2022

GTx (United States)
2020

University of Chicago
2020

Mayo Clinic in Arizona
2014-2018

Fondazione Vincenzo Pansadoro
2018

No AccessJournal of UrologyAdult Urology1 Aug 2016Positive Surgical Margins Increase Risk Recurrence after Partial Nephrectomy for High Renal Tumors Paras H. Shah, Daniel M. Moreira, Zhamshid Okhunov, Vinay R. Patel, Sameer Chopra, Aria A. Razmaria, Manaf Alom, Arvin K. George, Oksana Yaskiv, Michael J. Schwartz, Mihir Desai, Manish Vira, Lee Richstone, Jaime Landman, Arieh L. Shalhav, Inderbir Gill, and Louis Kavoussi ShahParas Shah Department Urology, Smith Institute North Shore LIJ, New...

10.1016/j.juro.2016.02.075 article EN The Journal of Urology 2016-02-20

Background: Healthcare professionals (HCPs) on the front lines against COVID-19 may face increased workload, and stress. Understanding HCPs risk for burnout is critical to supporting maintaining quality of healthcare during pandemic. Methods: To assess exposure, perceptions, possible pandemic we conducted a cross-sectional survey. The main outcomes measures were self-assessment other experiences attitudes associated with working Findings: A total 2,707 from 60 countries participated in this...

10.1101/2020.05.17.20101915 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2020-05-22

Contemporary predictive tools for percutaneous nephrolithotomy outcomes include the Guy stone score, S.T.O.N.E. nephrolithometry and CROES nephrolithometric nomogram. We compared each scoring system in same cohort to determine which was most of surgical outcomes.We retrospectively reviewed records patients who underwent between 2009 2012 at a total 3 academic institutions. calculated score nomogram based on preoperative computerized tomography images. A single observer institution all images...

10.1016/j.juro.2014.07.104 article EN The Journal of Urology 2014-08-01

Abstract Background: Studies suggest that obesity is associated with lower risk of prostate cancer but more aggressive cancers. As lowers PSA levels, these observations may be influenced by detection bias. We examined the association between and low- high-grade in REDUCE, which biopsies were largely independent PSA. Methods: The REDUCE study tested dutasteride for reduction men a 2.5 to 10.0 ng/mL negative biopsy. Study participants included 6,729 who underwent at least one on-study baseline...

10.1158/1055-9965.epi-14-0795 article EN Cancer Epidemiology Biomarkers & Prevention 2014-09-28

A recent meta-analysis showed that aspirin was associated with reduced prostate cancer risk. As anti-inflammatory medications lower PSA levels, whether these findings reflect detection or risk is unknown. We tested the association between and nonaspirin NSAID use on diagnosis in REDUCE, where all men received biopsies at 2 4 years largely independent of PSA. REDUCE dutasteride for reduction a 2.5 to 10.0 ng/mL negative prestudy biopsy.We examined aspirin, NSAIDs, both total, low-grade...

10.1158/1078-0432.ccr-14-2235 article EN Clinical Cancer Research 2014-12-18

To compare the predictive performance and potential clinical usefulness of risk calculators European Randomized Study Screening for Prostate Cancer (ERSPC RC) with without information on prostate volume.We studied 6 cohorts (5 1 US) a total 15,300 men, all biopsied pre-biopsy TRUS measurements volume. Volume was categorized into 3 categories (25, 40, 60 cc), to reflect use digital rectal examination (DRE) volume assessment. Risks cancer were calculated according ERSPC DRE-based RC (including...

10.1007/s00345-011-0804-y article EN cc-by-nc World Journal of Urology 2011-12-27

The relationship between prostate-specific antigen (PSA) level and prostate cancer risk remains subject to fundamental disagreements. We hypothesized that the of on biopsy for a given PSA is affected by identifiable characteristics cohort under study.We used data from five European three U.S. cohorts men undergoing cancer; six were population-based studies two clinical cohorts. association was calculated separately each using locally weighted scatterplot smoothing.The final set included...

10.1158/1078-0432.ccr-10-1328 article EN Clinical Cancer Research 2010-08-25

Purpose Cigarette smoking is a recognized risk factor for renal cell carcinoma (RCC), but little data are available on the association between and RCC biology. We investigated cigarette stage in large contemporary multiethnic surgical cohort. Patients Methods retrospectively reviewed demographic, clinical, pathologic of patients undergoing surgery 2000 2009. Advanced was defined as metastatic disease, ≥ T3, and/or lymph node involvement. Self-reported history included status, duration,...

10.1200/jco.2010.30.9484 article EN cc-by Journal of Clinical Oncology 2011-04-19

BACKGROUND The current study was performed to evaluate whether baseline acute and chronic prostate inflammation among men with an initial negative biopsy for cancer (PCa) increased the risk of subsequent PCa detection in a clinical trial systematic biopsies. METHODS A retrospective analysis 6238 aged 50 years 75 prostate‐specific antigen levels between 2.5 ng/mL 10 prior REduction by DUtasteride Events who completed 2‐year biopsy. PCa, inflammation, were assessed central review. association...

10.1002/cncr.28349 article EN Cancer 2013-12-09

We evaluated associations between histological prostate inflammation, and the development progression of benign prostatic hyperplasia/lower urinary tract symptoms in men randomized to placebo REDUCE (Reduction by Dutasteride Prostate Cancer Events) study a 4-year period.The association acute chronic inflammation detected on baseline biopsies hyperplasia related parameters, including I-PSS (International Symptom Score) volume, at multiple time points during 4 years enrolled cancer prevention...

10.1016/j.juro.2016.06.090 article EN The Journal of Urology 2016-07-03

We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and those up staged to pathological T3a.We retrospectively reviewed the records of 1,250 who underwent or clinically localized between 2006 2014. Recurrence-free was estimated using Kaplan-Meier method evaluated as a function type with log rank test Cox models, adjusting clinical, radiological characteristics.A total 86 recurrences (7%) were observed during...

10.1016/j.juro.2017.03.012 article EN The Journal of Urology 2017-03-06

Robot-assisted radical prostatectomy has undergone rapid dissemination driven in part by market forces to become the most frequently used surgical approach management of prostate cancer. Accordingly, a critical analysis its volume-outcome relationship important health policy implications. Therefore, we evaluated association hospital robot-assisted volume with perioperative outcomes, and examined distribution procedure contextualize relationship.We identified 140,671 men who underwent from...

10.1016/j.juro.2017.01.067 article EN The Journal of Urology 2017-01-30

BACKGROUND The current study was conducted to analyze the association between cigarette smoking and metastasis (the primary outcome) as well time biochemical disease recurrence (BCR), metastasis, castration‐resistant prostate cancer (CRPC), cancer‐specific overall mortality (secondary outcomes) after radical prostatectomy among men from Shared Equal Access Regional Cancer Hospital cohort. METHODS A retrospective analysis performed of 1450 subjects for whom status available preoperative...

10.1002/cncr.28423 article EN Cancer 2013-10-11

What's known on the subject? and What does study add? Given that percutaneous cryoablation (PCA) is a relatively new procedure, there are few studies published this treatment with almost no long‐term follow‐up. The approach, while not first choice for RCC, may be most appropriate older patients several comorbidities as it offers less invasive outpatient management of small renal masses (SRMs). It therefore important to measure procedural outcomes noting rates complications reasons failure or...

10.1111/j.1464-410x.2012.11538.x article EN BJU International 2012-10-26

Objectives To examine whether prostate‐specific antigen doubling time ( PSADT ) correlates with metastases, all‐cause mortality ACM ), and prostate cancer‐specific PCSM to identify thresholds that can be used clinically for risk stratification in men M0 castration‐resistant cancer CRPC ). Materials Methods We collected data on 441 2000–2015 at five Veterans Affairs hospitals. Cox models were test the association between log‐transformed development of metastasis, . thresholds, we categorized...

10.1111/bju.13856 article EN BJU International 2017-03-28
Coming Soon ...